Study of the Traditional Japanese Medicine Keishi-ka-shakuyaku-daio-to TJ-134 Compared to Lactomin for Treating Symptomatic Pneumatosis Cystoides Intestinalis in Adults

What this Trial Is About

This trial evaluates the traditional Japanese medicine Keishi-ka-shakuyaku-daio-to TJ-134 in patients with symptomatic pneumatosis cystoides intestinalis PCI. It compares the effects of TJ-134 with a control treatment, lactomin, over an 8-week period. The study aims to understand how these treatments affect abdominal symptoms and CT findings related to PCI. Participants are randomly assigned to receive either TJ-134 7.5g per day, which contains a mixture of peony root, cinnamon bark, jujube, glycyrrhiza, rhubarb, and ginger, or lactomin 3g per day for 8 weeks. Treatment is administered daily, and the study uses a parallel-group design with randomization to one of the two treatments. Throughout the study, abdominal symptoms are assessed and abdominal CT scans are performed at enrollment and after 8 weeks of treatment. Researchers measure changes in CT findings and symptom improvements such as bloating and abdominal pain. This helps evaluate the treatment effects on PCI over the treatment period under the supervision of the research team.

The Beneficial Effect of TJ-134 for Patients With Symptomatic Pneumatosis Cystoides Intestinalis